stockportfolio.pro
Medtronic plc P/E Ratio 2013–2026
Medtronic plc (MDT) annual price-to-earnings ratio by fiscal year, computed from SEC filings. Compound growth +6.5%/yr over 13 years.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2026 | — | — |
| FY 2025 | 22.76 | -16.5% |
| FY 2024 | 27.26 | -6.8% |
| FY 2023 | 29.26 | +19.1% |
| FY 2022 | 24.56 | -41.9% |
| FY 2021 | 42.25 | +82.5% |
| FY 2020 | 23.15 | +8.2% |
| FY 2019 | 21.40 | -25.0% |
| FY 2018 | 28.52 | +25.6% |
| FY 2017 | 22.71 | -8.0% |
| FY 2016 | 24.68 | +5.5% |
| FY 2015 | 23.40 | +62.2% |
| FY 2014 | 14.43 | +43.6% |
| FY 2013 | 10.05 | — |
Source: Medtronic plc SEC filings — fiscal-year-end price ÷ diluted EPS. Refreshed nightly.
See the full picture for Medtronic plc
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeMedtronic plc — frequently asked questions
What is Medtronic plc's price-to-earnings ratio?
Medtronic plc (MDT) reported price-to-earnings ratio of 22.76 for fiscal year 2025, per its SEC filings.
How has Medtronic plc's price-to-earnings ratio changed over time?
Between fiscal 2013 and 2026, MDT's price-to-earnings ratio grew at roughly 6.5% per year (compound annual rate), from 10.05 to 22.76.
Where does this data come from?
Figures are computed from Medtronic plc's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.